When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LPCN - Lipocine enters settlement and license agreement with Clarus Therapeutics
Lipocine Inc.
designer491/iStock via Getty Images Lipocine ([[LPCN]] -2.3%) has entered into a global settlement and license agreement with Clarus Therapeutics to resolve outstanding claims in an on-going intellectual property dispute. Terms of the settlement were not disclosed. Last month, Cantor Fitzgerald initiated coverage of Lipocine with an overweight rating and a price target that equated to 121% upside.